Patent ID: 6855678
Filing Date: 2005-02-15
Classification: A61L,C11D

Abstract:
1. A medical residue treatment composition which includes: at least one surfactant present in a range of about 0.05% to 15% by weight; at least one solvent; at least one co-solvent; at least one nitrogen containing biocide present in an amount from 0.5% to 20% by weight; and at least one organic chelating agent selected from the lithium salts of hydroxyorganic or organic acids; the lithium salts of a carbonate or bicarbonate or mixtures thereof; the lithium salts of carboxylated and substituted diethylamine; the lithium salts of substituted derivatives of ethylenediamine, lithium lactate, and dilithium citrate; lithium lauryl sulphate; lithium hydroxide; lithium triphosphate; lithium citrate; lithium tartrate; lithium methylmethacrylate; lithium glycolate; lithium acetate; lithium phosphate; and trilithium trinitriloacetate.